While the MyCancerGenome API is a valuable resource, itâs important to recognize its limitations:
It relies on the availability and accuracy of the underlying data sources. It may not cover all gene mutations or therapeutic options, particularly new or emerging ones. Integration into existing systems may require technical expertise.
